큐리오시스
494120KOSDAQ46.1 / 100
Reference Date: 2026-09-08
Company InformationBased on 2025 Annual Report
Business Overview
Curiosys is a bio small parts supplier established in 2015, specializing in lab automation solutions. The company develops, produces, and sells bio research equipment, lab automation products, and medical devices, with key offerings including live-cell imaging systems (Celloger®), cell purification systems (Cellpuri®), and digital pathology systems (MSP®). Recognized globally with awards such as R&D100 and CES Innovation Awards, Curiosys leverages its ISO and GMP-certified production facility in Yongin, Gyeonggi, to enhance its global manufacturing capabilities.
Number of Employees
93people
Average Salary
47.8M KRW
Score Calculation Basis
Detailed Financial Score
4.0x industry avg (risky)
Well below industry avg
Half of industry avg (excellent)
Detailed News Sentiment
- Positive[iR52 장영실상] 시간당 미생물 4000개 99% 정확도로 선별
큐리오시스의 미생물 자동 선별 장비 CPX가 IR52 장영실상 수상으로 기술 혁신성 인정받아 주가 상승 기대.
- Neutral원텍·큐리오시스 등 ‘코스닥 라이징스타’ 8곳 새로 뽑혀
The announcement highlights new Rising Star companies on KOSDAQ but does not directly impact 큐리오시스's stock performance.
- Positive큐리오시스, '오가노이드' 신약 개발 시장 공략…그래디언트와 MOU 체...
큐리오시스는 그래디언트 바이오컨버전스로부터의 MOU를 통해 오가노이드 기반 신약 개발 시장에서의 혁신적인 접근법을 확보하며 긍정적인 전망을 얻었다.
Detailed Momentum
Near 52w low (0%, downtrend)
1m -23.56% (strong drop)
Volume decreasing
Detailed Disclosure
- Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-09-04
- Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-08-28
- Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-08-20
- Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-08-18
- Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-08-10
